Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. - Wikidata - awgldk - TriplyDB

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

http://www.wikidata.org/entity/Q43183165

about

Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival Role of osteopontin in systemic lupus erythematosus Mechanisms linking excess adiposity and carcinogenesis promotion Osteopontin: At the cross-roads of myocyte survival and myocardial function Effects of canonical NF-κB signaling pathway on the proliferation and odonto/osteogenic differentiation of human stem cells from apical papilla.Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients.Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies.Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood.Osteopontin Expression in Patients with Hepatolith Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis.Low expression of GNAI3 predicts poor prognosis in patients with HCC.Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.RAN GTPase and Osteopontin in Pancreatic Cancer.Circulating markers for prognosis of hepatocellular carcinoma.Osteopontin as a therapeutic target for cancer.Targeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling.Osteopontin -- a promising biomarker for cancer therapy.The role of osteopontin expression in melanoma progression.Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells.Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays.OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.Osteopontin as a marker for response to pegylated interferon Alpha-2b treatment in Chronic HCV Saudi patients.microRNAs and Endometrial Pathophysiology.SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling.Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, αVβ3 and CD44.Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

P2860

Q26749570-E807803C-4CB8-4614-9B76-FBC7E9094B38 Q26853543-5D5CB068-2CDA-4331-A0F9-79A0C5CD441A Q27006644-34454DA9-1A7C-4B99-BD3F-B6F6AB09CA54 Q27022929-453A35A0-8D4D-44BF-8E48-A467E1057E30 Q28248833-314B601B-1610-45BE-88E0-7FB0F0CB7277 Q33597930-DA086C3D-4D1D-4F68-8204-77CB11BDE7AF Q33867375-CF5B41E6-BD33-4DC2-9C10-2C54598BDC04 Q34036685-8EAD3756-596D-4F15-AD65-5E7014575672 Q34039967-CF34129D-ECFA-403C-B27F-ED6DF638284A Q34775377-EDF0712E-7E91-40E7-8E2A-C7E2A5AB9F1E Q36250701-D28CED25-DAC8-459B-877B-FF541356D312 Q36408616-AA6C0DBF-04FF-4FC3-8BB1-AAA37EE2578D Q36425495-CC730EBD-BEDE-44A9-B24E-011B4BDE17A4 Q36493158-249E67AD-49B1-4129-9C1F-FC95D277C957 Q36503987-CC008088-0DAB-419B-BD9C-F53CE3BE76CE Q36578825-94EF8F19-3789-4B8B-B29B-B7B55FC40B56 Q37415614-8CAA569A-9BFD-4F6E-9D86-1287A25AF2E3 Q37688419-A4666917-0964-497F-964C-550C1D8455A2 Q37707655-83406DBA-6591-41F2-ACF3-8F2B410A312B Q37707767-097B4B4B-7EF3-4339-86C5-C261D3DCBCB5 Q37707966-1E6F7CE8-8500-48F6-9E81-83D22C93661F Q38103946-97B308AC-1DF0-4D1A-90BB-03A58FFA6FDE Q38217758-30D94F7A-30F4-4A35-948D-02DE9E5A11C5 Q38354012-8680BCB6-8213-47F2-990D-3C4373F3B260 Q38619009-9DA09DEF-7257-46D4-9CE0-A4075939C0DB Q40973252-B04EB1FD-FEA7-44D9-A0B2-791D5CC91D0F Q41020428-3D03002E-0200-4A3C-83EE-B29FB6CC8190 Q41504856-370C461E-7AE0-4DBD-B837-E96C80529182 Q42200175-4830A71A-EC83-40C8-9F12-18FEC4515D9E Q45737032-DEF26419-2386-4E6C-BD01-7B8041995F8F Q46606704-79361CEF-D75A-42D1-90DA-343E8492D2B0 Q50544691-C6E36C8C-DE23-4305-833B-F5D6371DE35B Q51734190-398980BC-277F-4052-A081-67EA0AE3DEDB Q52718495-5F188C53-88E7-44A7-ADD7-90ADE8440CD8 Q53550064-E06450A2-405B-475D-97B0-DEEFFCD01EDA

P2860

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

http://www.wikidata.org/entity/Q43183165

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@en

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@nl

type

label

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@en

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@nl

prefLabel

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@en

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@nl

P1433

Q43183165-6240763B-9DEC-4AA5-B87F-75D2F10DD122

P1476

Q43183165-F7C54956-92B2-4FA1-8E6C-165C3F1352FF

P2093

Q43183165-753C0C45-4237-46B1-9A13-61539D8B65D8

Q43183165-B6DE8830-DD5F-481B-AEBF-40E9FE3FFE97

Q43183165-D0D53B10-E5FE-44E7-B1FD-6B8B761BAA1A

Q43183165-D2E8250B-159B-4D96-BC3E-5437DEC41BCC

Q43183165-D9FDAA97-C24F-4783-BBF5-6C0E1187B881

Q43183165-EF708542-471F-46D1-8530-3F8779E7CAAB

Q43183165-F6CA112A-C923-4726-8C96-A8886F0FC504

P2860

Q43183165-0165B4A5-FDAC-4129-A2DB-FCAD91355F50

Q43183165-0272C6B2-665E-4978-A90B-D94304F8E268

Q43183165-02D1CA91-033A-4846-9DB9-7C9F7B20E344

Q43183165-037220CD-5701-4662-8841-A070C1B068F9

Q43183165-0586DA4D-ED82-4B6B-A47C-123184B875BE

Q43183165-0596D3B9-F766-4BEB-AADA-69100ECFAE5A

Q43183165-076F5E86-D9AB-45A1-8F1A-CB057DE2C218

Q43183165-0BA6066F-D297-40ED-BFDF-9FC1034719D1

Q43183165-0C5993E0-E761-4BE2-A764-65EF7E01E85E

Q43183165-109B6E37-6157-46D6-9781-07E1A84F321B

P304

Q43183165-6CC1DD9D-3E50-4815-8666-70A39A8FB17A

P31

Q43183165-85F5D3BF-CF12-4B4A-8B85-73B857345617

Q43183165-a63d8d12-4fc7-4e02-9492-1a0571bb3742

P356

Q43183165-FC327E03-11F9-4070-822A-5CC52CE6FFED

P407

Q43183165-5A80F586-776A-4F65-9B06-E5758423EA52

P433

Q43183165-0D93458F-2CBA-4C94-A1AD-F356A0EBC349

P478

Q43183165-E1646DD6-EAF3-4508-87AA-3F13901CCBD5

P50

Q43183165-542FC96F-B3A2-402F-A9E0-5012FA49209F

P577

Q43183165-C4948C88-4984-4C04-B65B-5F4F9ABD9415

P5875

Q43183165-23732247-A875-48E3-BA24-C98FDB212BE8

P698

Q43183165-A4CC1FC9-9661-46C7-8BD9-975839B5AE78

P921

Q43183165-92E6DB12-7CB8-46D3-9A8F-047D77C205B0

P932

Q43183165-FCE35397-AA65-444F-AD8B-F0D2DAD7B837

P356

WJG.V18.I30.3923

P1433

World Journal of Gastroenterology

P1476

Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

@en

P2093

Dong-Xing Cao

http://www.w3.org/2001/XMLSchema#string

Ester Khin

http://www.w3.org/2001/XMLSchema#string

Guo-Hao Wu

http://www.w3.org/2001/XMLSchema#string

Nikki P Lee

http://www.w3.org/2001/XMLSchema#string

Xiao-Ou Jiang

http://www.w3.org/2001/XMLSchema#string

Yick Liang Lum

http://www.w3.org/2001/XMLSchema#string

Zhi-Jie Li

http://www.w3.org/2001/XMLSchema#string

P2860

Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma

Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells

cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)

Osteopontin: role in cell signaling and cancer progression

Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

An in vivo platform for tumor biomarker assessment.

The metastasis gene osteopontin: a candidate target for cancer therapy.

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells

Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue

P304

3923-3930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I30.3923

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230716170

http://www.w3.org/2001/XMLSchema#string

P698

22912540

http://www.w3.org/2001/XMLSchema#string

P921

P932

3419986

http://www.w3.org/2001/XMLSchema#string